Patent · US Active

USP2a peptides and antibodies

US9056919B2 · kind B2 · utility

0Cited by
0References
5Claims
0Family size

Assignee

Inventor

Key dates

Filing dateOct 24, 2012
Grant dateJun 16, 2015
Priority date
Expiry dateOct 24, 2032

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/56
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The invention relates to novel USP2a peptides and antibodies, as well as nucleic acids related to them. The peptides, antibodies and the nucleic acids are useful for the detection, staging and monitoring of the progression of cancer, as well as for determining or monitoring the efficacy of treatment.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.